Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cervantes-Castaneda RAA et al. - Intravitreal bevacizumab is a useful and therapeutically beneficial agent in the treatment of refractory uveitic macular edema. Some patients will require adjunctive intravitreal bevacizumab injections or the use of combination therapy with intravitreal triamcinolone acetonide.


Today in Clinical Pharmacology...keeping you current

Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09

Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09

Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09

Today in Retina...keeping you current

Value of retinal examination in hypertensive encephalopathy
Journal of Human Hypertension, 11/03/09

Retinopathy of Prematurity
NeoReviews, 11/04/09

Late Increased Risk of Retinal Detachment after Cataract Extraction
American Journal of Ophthalmology, 10/30/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address